Indraprastha Medical Corporation Share Price
28 Aug, 2026 3:59 PM (IST)
Indraprastha Medical Corporation Performance
- Today's Low
- ₹366
- Today's High
- ₹373
- 52 Week Low
- ₹342
- 52 Week High
- ₹641
- Open Price₹370
- Previous Close₹369
- Volume126,120
- 50 DMA₹375.80
- 100 DMA₹385.40
- 200 DMA₹402.40
Indraprastha Medical Corporation Chart
Investment Returns
- Over 1 Month + 1.48%
- Over 3 Month -3.23%
- Over 6 Month -8.46%
- Over 1 Year -16.16%
Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!
Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 17.9
- PEG Ratio
- 1.5
- Market Cap Cr
- 3,374
- P/B Ratio
- 4.2
- Average True Range
- 9.1
- EPS
- 20.5
- Dividend Yield
- 1.2
- MACD Signal
- -1.2
- RSI
- 45.41
- MFI
- 28.85
Latest Stock News Updates
1)The AGM of the Company will be held on Thursday, 24th September, 2026. 2) The Record date for purpose of declaration of Dividend is 18th September, 2026. 3) The cut-off date for determining the members eligible to vote is 18th September, 2026.
- BSE India
- 16 hours 13 minutes ago
<h3><span style="font-size:16px;"><strong>Healthcare Facilities company Indraprastha Medical Corporation announced Q1FY27 results</strong></span></h3> <p _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c2478508423="">The company reported Revenue from operations of Rs 406.15 crore in Q1FY27, representing a YoY growth of 11.26% from Rs 365.06 crore in Q1FY26 and a QoQ increase of 11.33% compared to Rs 364.81 crore in Q4FY26.</li> <li _ngcontent-ng-c2478508423="">Total income reached Rs 414.57 crore in Q1FY27, showing a YoY increase of 11.46% from Rs 371.96 crore in Q1FY26 and a QoQ growth of 11.40% from Rs 372.14 crore in Q4FY26. For the full year FY26, total income stood at Rs 1,511.26 crore.</li> <li _ngcontent-ng-c2478508423="">Profit before tax (PBT) for Q1FY27 stood at Rs 74.82 crore, an increase of 9.53% YoY compared to Rs 68.31 crore in Q1FY26 and a 36.01% increase QoQ from Rs 55.01 crore in Q4FY26.</li> <li _ngcontent-ng-c2478508423="">Profit after tax (PAT) for the quarter ended 30th June, 2026, was Rs 55.85 crore, marking a YoY growth of 8.53% from Rs 51.46 crore in Q1FY26 and a QoQ growth of 33.93% from Rs 41.70 crore in Q4FY26.</li> <li _ngcontent-ng-c2478508423="">Total comprehensive income for Q1FY27 was Rs 58.10 crore, compared to Rs 55.94 crore in Q1FY26 (YoY growth of 3.86%) and Rs 40.56 crore in Q4FY26 (QoQ growth of 43.24%).</li> <li _ngcontent-ng-c2478508423="">Earnings per share (EPS) for Q1FY27 was recorded at Rs 6.09, up from Rs 5.61 in Q1FY26 and Rs 4.55 in Q4FY26. The EPS for the full year FY26 was Rs 20.03.</li> <li _ngcontent-ng-c2478508423="">The paid-up equity share capital (Face value Rs 10/- each) remained constant at Rs 91.67 crore.</li> </ul> <p _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Business Highlights:</strong></p> <ul> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Organizational Structure:</strong> As of 30th June, 2026, the company does not have any subsidiary, associate, or joint venture companies.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Corporate Actions:</strong> The Board of Directors fixed 18th September, 2026, as the record date for determining shareholders entitled to the dividend for the year FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Auditor Appointments:</strong> The Board approved the re-appointment of M/s Devarajan Swaminathan and Co. – Cost Accountants, as Cost Auditors for the financial year FY27.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5769871/" target="_blank">Result PDF</a></p>
- Trendlyne
- 3 weeks 1 day ago
we hereby submit copies of the public notice of the Financial results , published on 7th August, 2026, in the "Financial Express", all India Editions, in English Language and in " Jansatta", in Delhi Edition, in Hindi Language.
- BSE India
- 3 weeks 1 day ago
Indraprastha Medical Corporation Financials
Indraprastha Medical Corporation Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹372.00
- 50 Day
- ₹375.80
- 100 Day
- ₹385.40
- 200 Day
- ₹402.40
Resistance and Support
- R3 378.20
- R2 375.40
- R1 371.70
- S1 365.20
- S2 362.40
- S3 358.80
Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends
About Indraprastha Medical Corporation
Indraprastha Medical Corporation s a super specialty hospital commissioned in December 1995 in collaboration with the New Delhi administration. The hospital houses over 50 medical specialties including multi-organ transplants, non-invasive neuro-surgeries and day care procedures. View More- NSE Symbol
- INDRAMEDCO
- BSE Symbol
- 532150
- ISIN
- INE681B01017
Similar Stocks to Indraprastha Medical Corporation
Popular Stocks
Indraprastha Medical Corporation FAQs
Indraprastha Medical Corporation share price is ₹368 As on 30 August, 2026 | 08:06
The Market Cap of Indraprastha Medical Corporation is ₹3374 Cr As on 30 August, 2026 | 08:06
The P/E ratio of Indraprastha Medical Corporation is 17.9 As on 30 August, 2026 | 08:06
The PB ratio of Indraprastha Medical Corporation is 4.2 As on 30 August, 2026 | 08:06
The 52 week High & Low of Indraprastha Medical Corporation is ₹640.8/₹342 respectively As on 30 August, 2026 | 08:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.